Salata R A, Pearson R D, Ravdin J I
J Clin Invest. 1985 Aug;76(2):491-9. doi: 10.1172/JCI111998.
Capable effector mechanisms in the human immune response against the cytolytic, protozoan parasite Entamoeba histolytica have not been described. To identify a competent human effector cell, we studied the in vitro interactions of normal human polymorphonuclear neutrophils, peripheral blood mononuclear cells (PBMC), monocytes (MC), and MC-derived macrophages with virulent axenic amebae (strain HMI-IMSS). Amebae killed neutrophils, PBMC, MC, and MC-derived macrophages (P less than 0.001), without loss of parasite viability. The addition of heat-inactivated immune serum did not enable leukocytes to kill amebae, nor did it protect these host cells from amebae. MC-derived macrophages, activated with lymphokine elicited by the mitogens conconavalin A, phytohemagglutinin, or an amebic soluble protein preparation (strain HK9), killed 55% of amebae by 3 h in a trypan blue exclusion assay (P less than 0.001); during this time, 40% of the activated macrophages died. Lysis of amebae was confirmed using 111Indium oxine radiolabeled parasites and was antibody independent. Macrophage death appeared to be due to the deleterious effect of lysed amebae rather than the contact-dependent effector mechanisms of E. histolytica. Adherence between activated macrophages and amebae was greater than that between other leukocytes and amebae (P less than 0.001). Microscopic observations, kinetic analysis of the killing of amebae by activated macrophages, and suspension of amebae with adherent activated macrophages in a 10% dextran solution indicated that contact by activated macrophages was necessary to initiate the killing of amebae. Catalase but not superoxide dismutase inhibited the amebicidal capacity of activated macrophages (P less than 0.001). However, activated macrophages from an individual with chronic granulomatous disease were able to kill amebae, but not as effectively as normal cells (P less than 0.01). In summary, activated MC-derived macrophages killed virulent E. histolytica trophozoites through a contact-dependent, antibody-independent mechanism involving oxidative-dependent and -independent processes.
人类针对溶细胞性原生动物寄生虫溶组织内阿米巴的免疫反应中,尚未描述有能力的效应机制。为了鉴定一种有效的人类效应细胞,我们研究了正常人多形核中性粒细胞、外周血单核细胞(PBMC)、单核细胞(MC)以及MC来源的巨噬细胞与有毒力的无菌阿米巴(菌株HMI-IMSS)的体外相互作用。阿米巴杀死了中性粒细胞、PBMC、MC和MC来源的巨噬细胞(P<0.001),且寄生虫活力未丧失。添加热灭活的免疫血清既不能使白细胞杀死阿米巴,也不能保护这些宿主细胞免受阿米巴侵害。用伴刀豆球蛋白A、植物血凝素或阿米巴可溶性蛋白制剂(菌株HK9)诱导的淋巴因子激活的MC来源的巨噬细胞,在锥虫蓝排斥试验中,3小时内杀死了55%的阿米巴(P<0.001);在此期间,40%的活化巨噬细胞死亡。使用111铟氧喹啉放射性标记的寄生虫证实了阿米巴的裂解,且与抗体无关。巨噬细胞死亡似乎是由于裂解的阿米巴的有害作用,而不是溶组织内阿米巴的接触依赖性效应机制。活化巨噬细胞与阿米巴之间的黏附大于其他白细胞与阿米巴之间的黏附(P<0.001)。显微镜观察、活化巨噬细胞杀死阿米巴的动力学分析以及在10%葡聚糖溶液中将阿米巴与黏附的活化巨噬细胞悬浮表明,活化巨噬细胞的接触是启动杀死阿米巴所必需的。过氧化氢酶而非超氧化物歧化酶抑制活化巨噬细胞的杀阿米巴能力(P<0.001)。然而,来自慢性肉芽肿病个体的活化巨噬细胞能够杀死阿米巴,但不如正常细胞有效(P<0.01)。总之,活化的MC来源的巨噬细胞通过涉及氧化依赖性和非依赖性过程的接触依赖性、抗体非依赖性机制杀死有毒力的溶组织内阿米巴滋养体。